Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2018 2
2019 2
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
ADAR1 affects HCV infection by modulating innate immune response.
Pujantell M, Franco S, Galván-Femenía I, Badia R, Castellví M, Garcia-Vidal E, Clotet B, de Cid R, Tural C, Martínez MA, Riveira-Muñoz E, Esté JA, Ballana E. Pujantell M, et al. Among authors: garcia vidal e. Antiviral Res. 2018 Aug;156:116-127. doi: 10.1016/j.antiviral.2018.05.012. Epub 2018 Jun 12. Antiviral Res. 2018. PMID: 29906476
CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir.
Badia R, Ballana E, Castellví M, García-Vidal E, Pujantell M, Clotet B, Prado JG, Puig J, Martínez MA, Riveira-Muñoz E, Esté JA. Badia R, et al. Among authors: garcia vidal e. Nat Commun. 2018 Jul 16;9(1):2739. doi: 10.1038/s41467-018-05157-w. Nat Commun. 2018. PMID: 30013105 Free PMC article.
RNA editing by ADAR1 regulates innate and antiviral immune functions in primary macrophages.
Pujantell M, Riveira-Muñoz E, Badia R, Castellví M, Garcia-Vidal E, Sirera G, Puig T, Ramirez C, Clotet B, Esté JA, Ballana E. Pujantell M, et al. Among authors: garcia vidal e. Sci Rep. 2017 Oct 17;7(1):13339. doi: 10.1038/s41598-017-13580-0. Sci Rep. 2017. PMID: 29042669 Free PMC article.
Dual effect of the broad spectrum kinase inhibitor midostaurin in acute and latent HIV-1 infection.
Garcia-Vidal E, Badia R, Pujantell M, Castellví M, Felip E, Clotet B, Riveira-Muñoz E, Ballana E, Esté JA. Garcia-Vidal E, et al. Antiviral Res. 2019 Aug;168:18-27. doi: 10.1016/j.antiviral.2019.05.003. Epub 2019 May 8. Antiviral Res. 2019. PMID: 31077767
ADAR1 function affects HPV replication and is associated to recurrent human papillomavirus-induced dysplasia in HIV coinfected individuals.
Pujantell M, Badia R, Galván-Femenía I, Garcia-Vidal E, de Cid R, Alcalde C, Tarrats A, Piñol M, Garcia F, Chamorro AM, Revollo B, Videla S, Parés D, Corral J, Tural C, Sirera G, Esté JA, Ballana E, Riveira-Muñoz E. Pujantell M, et al. Among authors: garcia vidal e. Sci Rep. 2019 Dec 27;9(1):19848. doi: 10.1038/s41598-019-56422-x. Sci Rep. 2019. PMID: 31882741 Free PMC article.
Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy.
Castellví M, Felip E, Ezeonwumelu IJ, Badia R, Garcia-Vidal E, Pujantell M, Gutiérrez-Chamorro L, Teruel I, Martínez-Cardús A, Clotet B, Riveira-Muñoz E, Margelí M, Ballana E. Castellví M, et al. Among authors: garcia vidal e. Cancers (Basel). 2020 Mar 18;12(3):713. doi: 10.3390/cancers12030713. Cancers (Basel). 2020. PMID: 32197329 Free PMC article.
Evaluation of the Innate Immune Modulator Acitretin as a Strategy To Clear the HIV Reservoir.
Garcia-Vidal E, Castellví M, Pujantell M, Badia R, Jou A, Gomez L, Puig T, Clotet B, Ballana E, Riveira-Muñoz E, Esté JA. Garcia-Vidal E, et al. Antimicrob Agents Chemother. 2017 Oct 24;61(11):e01368-17. doi: 10.1128/AAC.01368-17. Print 2017 Nov. Antimicrob Agents Chemother. 2017. PMID: 28874382 Free PMC article.
Erratum: Castellví, M. et al. Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy. Cancers 2020, 12, 713.
Castellví M, Felip E, Ezeonwumelu IJ, Badia R, Garcia-Vidal E, Pujantell M, Gutiérrez-Chamorro L, Teruel I, Martínez-Cardús A, Clotet B, Riveira-Muñoz E, Margelí M, Esté JA, Ballana E. Castellví M, et al. Among authors: garcia vidal e. Cancers (Basel). 2020 Jun 29;12(7):E1728. doi: 10.3390/cancers12071728. Cancers (Basel). 2020. PMID: 32610575 Free article.
Feedback